ENP Newswire -
Release date- 03092014 - From
It will no longer be available from pharmacies without a prescription, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today. This follows advice previously issued by the MHRA in
'Patient safety is our priority - we continually monitor the safety of medicines after they are licensed so that we can take action if the need arises.
'If you are currently taking domperidone without a prescription and wish to continue, speak to your doctor or pharmacist at your next routine visit. There is no problem if you wish to stop and a healthcare professional can advise on suitable alternatives for nausea and vomiting.
'People who have been prescribed domperidone from their doctor should continue to take their medicine as instructed as their medical history and any tests will have been assessed before they are given this medicine. That is why we have changed this medicine to prescription only so that patients can be assessed for any underlying medical conditions that may affect their suitability for domperidone. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration.
'If you have experienced any side effects to this medicine you can report these to us at: www.mhra.gov.uk/yellowcard.'
Following this, the
A recall to pharmacy level only has been issued because this product should no longer be sold over the counter in pharmacies. Domperidone will now only be available as a prescription-only medicine (POM) with effect from
Most Popular Stories
- Bolivar Appointed to NSHMBA National Board
- When to Say No to Investors, Yes to Mentors
- Duke Energy, Strata Partner on Big Solar Project
- Rosneft Growth Slowed by Western Sanctions
- SBA Kicks off Hispanic Heritage Month
- Lindsay Lohan Claims She Handled Whitney Houston's Body Bag
- Ukraine Offers Temporary Autonomy to Rebel-held Areas
- Bently Creates Alabama Small Business Commission
- Creepers! Microsoft Buys 'Minecraft' Maker for $2.5 Billion
- Thousands Risk Losing Health Care Aid